Home › Funds › Coppell Advisory Solutions LLC › NVCR
Coppell Advisory Solutions LLC position in NVCR
NOVOCURE LTD · Health Care
Coppell Advisory Solutions LLC reported holding 38,953 shares of NVCR (NOVOCURE LTD) in its Q2 2026 13F filing — a position valued at US$4.9M, representing 0.40% of its reported portfolio and ranking #50 among its reported holdings. Coppell Advisory Solutions LLC has disclosed NVCR holdings in 4 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Coppell Advisory Solutions LLC's NVCR position evolved
Coppell Advisory Solutions LLC first disclosed a stake in NVCR in Q2 2024 at 910 shares (US$16K). The position peaked in Q2 2026 at 38,953 shares, worth US$4.9M. Across 4 filings, Coppell Advisory Solutions LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 38,953 shares valued at US$4.9M. Notable position changes include a 93% trim in Q4 2024 (shares fell 40% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 910 | $15.59K | New |
| Q3 2024 | 1.12K | $17.55K | Add |
| Q4 2024 | 76 | $2.29K | Reduce |
| Q2 2026 | 38.95K | $4.86M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVCR and 13F data
NVCR (NOVOCURE LTD) is a Health Care company. 32 other funds we track also report a position in NVCR — the largest reported positions include Soleus Capital Management, L.P. (US$150.2M), Palo Alto Investors LP (US$19.4M), C WorldWide Group Holding A/S (US$14.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVCR
- Soleus Capital Management, L.P. 9.91M sh · $150.19M · Q2 2026
- Palo Alto Investors LP 1.28M sh · $19.40M · Q2 2026
- C WorldWide Group Holding A/S 971.78K sh · $14.72M · Q2 2026
More on Coppell Advisory Solutions LLC
FAQ
How long has Coppell Advisory Solutions LLC held NVCR?
Coppell Advisory Solutions LLC has disclosed NVCR holdings in 4 of the last 9 reported quarters, going back to Q2 2024.
What is Coppell Advisory Solutions LLC's current position in NVCR?
As of Q2 2026, Coppell Advisory Solutions LLC holds 38.95K shares of NVCR (NOVOCURE LTD), valued at $4.86M, representing 0.40% of its reported portfolio and ranking #50.
Has Coppell Advisory Solutions LLC been buying or selling NVCR?
In the latest 13F filing (Q2 2026), Coppell Advisory Solutions LLC newly opened its position in NVCR. The position peaked in Q2 2026 at 38.95K shares.
Which other funds hold NVCR?
Other major institutional holders of NVCR include Soleus Capital Management, L.P., Palo Alto Investors LP, C WorldWide Group Holding A/S, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.